Free Trial

Short Interest in Cochlear Limited (OTCMKTS:CHEOY) Rises By 1,425.0%

Cochlear logo with Medical background

Cochlear Limited (OTCMKTS:CHEOY - Get Free Report) was the recipient of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 12,200 shares, an increase of 1,425.0% from the September 30th total of 800 shares. Based on an average daily volume of 11,800 shares, the short-interest ratio is presently 1.0 days.

Cochlear Stock Up 0.9 %

CHEOY stock traded up $0.85 during trading on Friday, reaching $94.76. The company had a trading volume of 4,955 shares, compared to its average volume of 4,057. Cochlear has a twelve month low of $76.12 and a twelve month high of $115.85. The firm has a 50-day simple moving average of $98.64 and a 200-day simple moving average of $104.75.

Cochlear Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, October 25th. Stockholders of record on Wednesday, September 18th will be issued a dividend of $0.1424 per share. The ex-dividend date is Wednesday, September 18th. This is a positive change from Cochlear's previous dividend of $0.03.

Analyst Ratings Changes

Separately, Royal Bank of Canada upgraded Cochlear to a "hold" rating in a research note on Friday, August 16th.

Read Our Latest Stock Report on Cochlear

Cochlear Company Profile

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Recommended Stories

Should you invest $1,000 in Cochlear right now?

Before you consider Cochlear, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cochlear wasn't on the list.

While Cochlear currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines